HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial Read more
Hyaluronic Acid Market Driven by Increasing Demand for Cosmetics and Expected to Grow over 21 Bn by 2032 Read more
EBC Financial Group Expands Asset Management Capabilities with Second Australian Financial Services Licence Read more
Galaxy Payroll Group Limited Announces Closing of the Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering Read more
Star Fashion Culture Holdings Limited Announces Closing of $8.6 Million Initial Public Offering Read more